Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.48 |
| ▸ | ATM | Q13315 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.41 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.41 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | PPARG | P37231 | 1/20 | 0.41 |
| ▸ | BCHE | P06276 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15548526 | 0.89 | KMT2A (0.49) | TDP1L3MBTL1ATMKDM4EALDH1A1 | |
| SCHEMBL4084312 | 0.87 | TDP1 (0.49) | TDP1L3MBTL1ATMKDM4EALDH1A1 | |
| SCHEMBL14578008 | 0.84 | KMT2A (0.43) | TDP1L3MBTL1ATMKDM4EALDH1A1 | |
| SCHEMBL15547525 | 0.83 | PTGS2 (0.47) | TDP1L3MBTL1KDM4EALDH1A1KMT2A | |
| SCHEMBL17459128 | 0.83 | L3MBTL1 (0.44) | L3MBTL1ATMKDM4EALDH1A1HTT | |
| SCHEMBL27721743 | 0.83 | KMT2A (0.44) | TDP1L3MBTL1KDM4EALDH1A1HTT | |
| SCHEMBL15547890 | 0.83 | ALOX15 (0.47) | L3MBTL1ATMKDM4EALDH1A1KMT2A | |
| SCHEMBL4085152 | 0.83 | KMT2A (0.49) | L3MBTL1ATMKDM4EALDH1A1KMT2A | |
| SCHEMBL1261877 | 0.82 | MEN1 (0.51) | TDP1L3MBTL1ATMKDM4EALDH1A1 | |
| SCHEMBL7751175 | 0.81 | TDP1 (0.47) | TDP1L3MBTL1ATMKDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10895840-B2 | Electrophotographic photosensitive member, process cartridge, and electrophotographic apparatus | CANON KABUSHIKI KAISHA (JP) | 2021-01-19 | — | — | US | disclosed |
| US-20200159135-A1 | ELECTROPHOTOGRAPHIC PHOTOSENSITIVE MEMBER, PROCESS CARTRIDGE, AND ELECTROPHOTOGRAPHIC APPARATUS | CANON KABUSHIKI KAISHA (JP) | 2020-05-21 | — | — | US | disclosed |
| US-10539888-B2 | Electrophotographic photosensitive member, process cartridge, and electrophotographic apparatus | CANON KABUSHIKI KAISHA (JP) | 2020-01-21 | — | — | US | disclosed |
| US-10042273-B2 | Electrophotographic photosensitive member, process cartridge and electrophotographic apparatus | CANON KABUSHIKI KAISHA (JP) | 2018-08-07 | — | — | US | disclosed |
| US-20170108790-A1 | ELECTROPHOTOGRAPHIC PHOTOSENSITIVE MEMBER, PROCESS CARTRIDGE AND ELECTROPHOTOGRAPHIC APPARATUS | CANON KABUSHIKI KAISHA (JP) | 2017-04-20 | — | — | US | disclosed |
| US-9599915-B2 | Electrophotographic photosensitive member, process cartridge, and electrophotographic apparatus | CANON KABUSHIKI KAISHA (JP) | 2017-03-21 | — | — | US | disclosed |
| US-20090186138-A1 | Method of Flavoring | GIVAUDAN SA (CH) | 2009-07-23 | — | — | US | disclosed |
| CN-1918133-A | Alpha-4 integrin mediated cell adhesion inhibitors for the treatment or prevention of inflammatory diseases | TANABE SEIYAKU CO (JP) | 2007-02-21 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090186138-A1 | Method of Flavoring | TAS2R5, TAS2R50, TAS2R10 | TDP1 4513/4885L3MBTL1 3164/4885ATM 2702/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.